Otros idiomas NanJing Pharmaceutical Company Limited

Acciones

600713

CNE000000KV1

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
4,88 ^CNY	-0,81 %		+0,41 %	+0,83 %

29/04	NanJing Pharmaceutical Company Limited presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
08/04	NanJing Medical planea emitir hasta 6.000 millones de yuanes en bonos a ultracorto plazo	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
NanJing Medical Plans to Issue Up to 6 Billion Yuan in Ultra Short-Term Bonds	08/04
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	07/04
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
NanJing Pharmaceutical Company Limited(XSSC:600713) added to S&P Global BMI Index	18/09/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
NanJing Pharmaceutical Company Limited entered into Framework Agreement to acquire 55% stake in Suzhou Tianqing Xingwei Pharmaceutical Co., Ltd., a 55% stake in Zhejiang Tianqing Zhongwei Pharmaceutical Co., Ltd., and a 100% of Lianyungang Chia Tai-Tianqing Pharmaceutical Co., Ltd.	21/12/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	23/08/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22
NanJing Medical’s Controlling Shareholder Boosts Stake to 44.2% For $158 Million	21/02/22
NanJing Pharmaceutical Company Limited announced that it has received CNY 997.999997 million in funding from Nanjing XinGong Investment Group Co., Ltd	14/02/22
Sichuan Luyan Pharmaceutical Co., Ltd. agreed to acquire Sichuan Yatong Pharmaceutical Co., Ltd. from NanJing Pharmaceutical Company Limited for CNY 19.9 million.	09/11/21
NanJing Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
NanJing Pharmaceutical Company Limited announced that it expects to receive CNY 999.999998 million in funding from Nanjing XinGong Investment Group Co., Ltd	10/09/21
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	20/08/21
Nanjing Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	27/04/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas NanJing Pharmaceutical Company Limited

Acciones

600713

CNE000000KV1

Otros idiomas

Filtros